Annual accounts & ratios
Source: NBB · 2024How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil–Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Fiscal year | 2024 |
|---|---|
| Revenue | €273k |
| EBITDA | €68k |
| Net profit | €42k |
| Cash flow | €55k |
| Staff costs | €4k |
| Income taxes | €12k |
| Dividends | — |
| Total assets | €184k |
| Equity | €143k |
| Debt | €41k |
| of which ≤ 1y | €23k |
| of which > 1y | €17k |
| Working capital | €114k |
| Employees (FTE) | — |
| 2024 | |
|---|---|
| Current ratio | 5.86 |
| Quick ratio | 5.86 |
| Working capital ratio | 62.0% |
| Solvency | 77.8% |
| Debt / equity | 0.28 |
| Long-term debt ratio | 0.12 |
| Interest coverage | 46.53 |
| Gross margin | 26.7% |
| Net margin | 15.2% |
| ROA | 22.7% |
| ROE | 29.1% |
| EBITDA margin | 25.0% |
| Days sales outstanding | 42d |
| Days payable outstanding | 9d |
| Inventory turnover | — |
| Days inventory (DSI) | — |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet — Assets | ||
| TOTAL ASSETS | 20/58 | €184k |
| Fixed assets | 21/28 | €46k |
| Formation expenses | 20 | €466 |
| Tangible fixed assets | 22/27 | €46k |
| Financial fixed assets | 28 | €47 |
| Current assets | 29/58 | €137k |
| Amounts receivable within one year | 40/41 | €33k |
| Cash & bank | 54/58 | €103k |
| Balance sheet — Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €184k |
| Equity | 10/15 | €143k |
| Contributions / capital | 10/11 | €10k |
| Reserves | 13 | €132k |
| Accumulated profits (losses) | 14 | €863 |
| Amounts payable | 17/49 | €41k |
| Amounts payable after one year | 17 | €17k |
| Amounts payable within one year | 42/48 | €23k |
| Trade debts payable within one year | 44 | €5k |
| Income statement | ||
| Turnover | 70 | €273k |
| Gross operating margin | 9900 | €73k |
| Operating result | 9901 | €55k |
| Financial charges | 65 | €1k |
| Result before taxes | 9903 | €54k |
| Income taxes | 67/77 | €12k |
| Net result for the period | 9904 | €42k |
| Result to be appropriated | 9905 | €42k |
Health barometer
FY 2024 · computedUnlock the full score breakdown, per-year score history and the indicative credit limit from Starter.
See plans →